Almost $1 billion: F&P defies market chatter

Almost $1 billion: F&P defies market chatter
Managing director Lewis Gradon said the first half of the last financial year was a period of extraordinary demand during the initial surges of covid-19. (Image: supplied)
Staff reporters
Fisher & Paykel Healthcare has reported half-year revenue down just 1% to $900 million, defying analyst expectations of a significant sales slowdown. Investors have been waiting since August to get an update on how the company is tracking, with management unable to offer guidance due to unpredictable sales during the pandemic.Analysts from two of New Zealand’s largest broking firms predicted a revenue decline between 7% and 9% as covid-related sales normalised.Instead, the healthcare exporter’s revenue dropped just 1% in th...

More Markets

NZ sharemarket claws back to end the week up 0.5%
Markets Market close

NZ sharemarket claws back to end the week up 0.5%

Index rumours drive prices on two shares. 

Graham Skellern 13 Dec 2024
Staff leave Meridian after retail 'reset'
Markets

Staff leave Meridian after retail 'reset'

Expect a very different approach from Meridian in 2025, executive says.

John Anthony 13 Dec 2024
NZX, NZSA want level playing field in climate reporting
Markets

NZX, NZSA want level playing field in climate reporting

Climate reporting liabilities for company directors could soon be eased.

Greg Hurrell 13 Dec 2024
Cannasouth delisting keeps Petterson in charge
Markets

Cannasouth delisting keeps Petterson in charge

Cannasouth major shareholders pushed to end voluntary administration they had called in.

Garth Bray 13 Dec 2024